We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$304M
AUM Growth
-$18.2M
Cap. Flow
+$23.9M
Cap. Flow %
7.87%
Top 10 Hldgs %
58.5%
Holding
65
New
11
Increased
20
Reduced
14
Closed
16

Top Buys

Rank Stock Value
1
INDI icon
indie Semiconductor
INDI
+$11.8M
2
ASPN icon
Aspen Aerogels
ASPN
+$11.4M
3
CMBM
Cambium Networks
CMBM
+$11.4M
4
SCPH
scPharmaceuticals
SCPH
+$11M
5
BDSX icon
Biodesix
BDSX
+$8.28M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$28.3M
2
MTRN icon
Materion
MTRN
+$19.3M
3
SEV
Sono Group N.V. Common Shares
SEV
+$8.93M
4
SIMO icon
Silicon Motion
SIMO
+$7.46M
5
ICAD
iCAD Inc
ICAD
+$3.69M

Sector Composition

Rank Sector Weight
1 Technology 50.28%
2 Healthcare 42.77%
3 Materials 3.88%
4 Industrials 1.63%
5 Miscellaneous 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DZSI
1
DELISTED
DZS Inc. Common Stock
DZSI
$22.7M 7.47%
1,787,275
+109,396
+7% +$1.39M
ADTN icon
2
Adtran
ADTN
$579M
$22.2M 7.3%
1,179,919
+18,900
+2% +$380K
TGAN
3
DELISTED
Transphorm, Inc. Common Stock
TGAN
$19.6M 6.47%
3,609,346
-163,529
-4% -$962K
TELA icon
4
TELA Bio
TELA
$58.2M
$19.3M 6.36%
1,679,281
+149,612
+10% +$1.34M
SCPH
5
DELISTED
scPharmaceuticals
SCPH
$18.3M 6.02%
2,550,234
+1,793,171
+237% +$11M
INDI icon
6
indie Semiconductor
INDI
$726M
$17.8M 5.87%
3,058,243
+1,605,477
+111% +$11.8M
AVNW icon
7
Aviat Networks
AVNW
$263M
$16.6M 5.48%
532,918
-3,000
-0.6% -$91.1K
ANIP icon
8
ANI Pharmaceuticals
ANIP
$1.73B
$14.4M 4.75%
358,106
+43,700
+14% +$1.64M
BDSX icon
9
Biodesix
BDSX
$304M
$14M 4.62%
+304,674
New +$8.28M
CMBM
10
DELISTED
Cambium Networks
CMBM
$12.7M 4.17%
584,106
+564,924
+2,945% +$11.4M
ASPN icon
11
Aspen Aerogels
ASPN
$426M
$11.8M 3.88%
+1,000,000
New +$11.4M
CAMP
12
DELISTED
CalAmp Corp.
CAMP
$10.4M 3.44%
101,215
-391
-0.4% -$33K
AVEO
13
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$10.4M 3.42%
695,358
-2,043,897
-75% -$28.3M
CTIC
14
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$8.45M 2.78%
+1,405,859
New +$7.67M
PRTK
15
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$7.77M 2.56%
4,156,891
+269,719
+7% +$672K
EOLS icon
16
Evolus
EOLS
$529M
$6.97M 2.3%
928,528
+728,528
+364% +$5.64M
BKTI icon
17
BK Technologies
BKTI
$273M
$5.61M 1.85%
337,945
+63,195
+23% +$823K
INFN
18
DELISTED
Infinera Corporation Common Stock
INFN
$5.56M 1.83%
+824,971
New +$5M
MRAM icon
19
Everspin Technologies
MRAM
$361M
$4.73M 1.56%
849,930
-4,500
-0.5% -$26.4K
AIRG icon
20
Airgain
AIRG
$68.9M
$4.72M 1.56%
725,484
-2,000
-0.3% -$14.4K
CGTX icon
21
Cognition Therapeutics
CGTX
$101M
$4.28M 1.41%
2,037,853
+1,239,518
+155% +$2.5M
COHR icon
22
Coherent
COHR
$58B
$3.51M 1.16%
+100,000
New +$3.48M
THER
23
DELISTED
THERATECHNOLOGIES INC COM
THER
$3.39M 1.12%
3,830,039
+916,972
+31% +$811K
APEN
24
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.15M 1.04%
316,436
-192,100
-38% -$1.43M
SCYX icon
25
SCYNEXIS
SCYX
$44.3M
$3.01M 0.99%
241,506
-3,126
-1% -$55.3K
1
2 3

Similar funds

CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

AIGH Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, AIGH Capital Management held 65 positions worth $304M, down 5.7% from $322M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

AIGH Capital Management deployed $23.9M of net new capital in Q4 2022, opening 11 new positions and adding to 20 existing holdings. Its largest new stake was Aspen Aerogels: 1,000,000 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 41% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was AVEO Pharmaceuticals, Inc., an estimated $28.3M trimmed.

  • AIGH Capital Management's largest Q4 2022 buy was Aspen Aerogels: 1,000,000 shares worth $11.8M.
  • AIGH Capital Management added most to indie Semiconductor in Q4 2022, an estimated $11.8M increase.
  • AIGH Capital Management's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $28.3M.
  • AIGH Capital Management fully exited Materion in Q4 2022, selling an estimated $19.3M.
  • AIGH Capital Management's ten largest holdings make up 59% of its $304M portfolio in Q4 2022.
  • AIGH Capital Management opened 11 new positions and closed 16 in Q4 2022.
  • AIGH Capital Management's portfolio value fell 5.7% quarter-over-quarter to $304M.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.